Cargando…
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) helicase NSP13 plays a conserved role in the replication of coronaviruses and has been identified as an ideal target for the development of antiviral drugs against SARS-CoV-2. Here, we identify a novel NSP13 helicase inhibitor punicala...
Autores principales: | Lu, Lian, Peng, Yun, Yao, Huiqiao, Wang, Yanqun, Li, Jinyu, Yang, Yang, Lin, Zhonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381947/ https://www.ncbi.nlm.nih.gov/pubmed/35985407 http://dx.doi.org/10.1016/j.antiviral.2022.105389 |
Ejemplares similares
-
Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti-aspergillus fumigatus dual efficacies in vitro
por: He, Yuhua, et al.
Publicado: (2021) -
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
por: White, Mark Andrew, et al.
Publicado: (2020) -
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
por: Yu, Mi-Sun, et al.
Publicado: (2012) -
ATPase and helicase activities of porcine epidemic diarrhea virus nsp13
por: Ren, Jie, et al.
Publicado: (2021) -
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
por: Gurung, Arun Bahadur
Publicado: (2020)